A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives
Filed under Antic. monoclonales, Anticuerpos, Antígenos, Cáncer, Inmunoterapia, Receptores by on .
Filed under Antic. monoclonales, Anticuerpos, Antígenos, Cáncer, Inmunoterapia, Receptores by Orlando R. Serrano Barrera on .
Leave a Comment